High-voltage impedance rise; mechanism and management in patients with transvenous implantable cardioverter-defibrillators: a case series.

ABSTRACT: Background:We describe a case series of patients for a gradual rise in daily, low-voltage sub-threshold measurement (LVSM) of shock (high-voltage, HV) impedance in a group of patients with Boston Scientific implantable cardioverter-defibrillators (ICDs) and investigate the cause of the abnormality. Case summary:Six patients presented with a gradual rise in HV impedance above normal range (132.5?±?20.8??). Patients were young with a mean age of 29?±?11?years, four patients had hypertrophic cardiomyopathy, one left ventricular non-compaction, and one long QT. All lead designs were silicon body with GORE polytetrafluoroethylene (ePTFE) coated coils, and a lower true shock impedance (TSI) was seen in all cases with full output synchronized shock. We compared the rate of HV impedance rise with our historical cohort of Boston ICDs using an unpaired t-test. The change in impedance per month was significantly higher amongst our six patients when compared with our cohort of Boston Scientific ICDs (3.2?±?1.9??/month vs. 0.0008?±?0.005??/month, P?

SUBMITTER: Monkhouse C 

PROVIDER: S-EPMC6939807 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature